Skip to main content
Lynda Schneider, MD, Allergy & Immunology, Boston, MA, Boston Children's Hospital

LyndaCSchneiderMD

Allergy & Immunology Boston, MA

Clinical & Laboratory Immunology

Professor of Pediatrics, Harvard Medical School

Dr. Schneider is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schneider's full profile

Already have an account?

Education & Training

  • Boston Children's Hospital
    Boston Children's HospitalFellowship, Allergy and Immunology, 1987 - 1990
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Pediatrics, 1983 - 1986
  • Sidney Kimmel Medical College
    Sidney Kimmel Medical CollegeClass of 1983

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1986 - 2021
  • American Board of Allergy and Immunology Allergy & Immunology
  • American Board of Allergy and Immunology Diagnostic Laboratory Immunology
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Boston Magazine Castle Connolly, 2010-2013
  • Fellow (FAAP) American Academy of Pediatrics
  • Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut Allergy  
    Todd D Green, David M Fleischer, Hey Chong, R Sharon Chinthrajah, Edwin H Kim, Stacie M Jones, Robert Wood, Bruce J Lanser, Lynda Schneider, Jacqueline A Pongracic, Wa..., JAMA
  • Original Article Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab  
    Dale T Umetsu, Rima Rachid, Jennifer LeBovidge, Lynda Schneider, ScienceDirect

Press Mentions

  • Baby Food Products for Early Allergen Introduction Hit Market
    Baby Food Products for Early Allergen Introduction Hit MarketMarch 14th, 2018
  • IL-31 Pathway May Lead to New Treatments for Pruritus
    IL-31 Pathway May Lead to New Treatments for PruritusAugust 18th, 2017
  • Boston Children's Hospital Release: Potential Breakthrough for Children with Peanut Allergies
    Boston Children's Hospital Release: Potential Breakthrough for Children with Peanut AllergiesOctober 31st, 2013
  • Join now to see all

Grant Support

  • Immune Response To Varicella Vaccination In Subjects With Atopic DermatitisNational Center For Research Resources2007
  • Genetics Of Atopic Dermatitis - Eczema Herpeticum (ADEH) StudyNational Center For Research Resources2007
  • Genetic And Environmental Risk Factors In Atopic DermatitisNational Center For Research Resources2007
  • Advn Biomarker Registry StudyNational Center For Research Resources2007
  • Edema2:Evaluation Of Dx-88'S Effects In Mitigating Angioedema, An OPEN Label STDNational Center For Research Resources2004–2006
  • Dx-88 In Hereditary AngioedemaNational Center For Research Resources2004–2005
  • Vapor Heated C-1 Inhibitor Immunotherapy In HaeNational Center For Research Resources2000–2002
  • Study Of Budesonide Nebulizing Suspension &Placebo In Asthmatic ChildrenNational Center For Research Resources1997–1999
  • OPEN Label Extension To A Study Of Four Dose Regimens Of BudesonideNational Center For Research Resources1997–1999
  • Trial Of Nebulized Budesonide For Moderate Asthma In ChildrenNational Center For Research Resources1996

Professional Memberships

Hospital Affiliations